Advertisement

Peripheral Monocyte Count Is Associated with Case Fatality after Intracerebral Hemorrhage

      Background

      Leukocytosis is associated with hemorrhage volume and early neurologic deterioration after intracerebral hemorrhage (ICH). We examined total white blood cell (WBC) count, absolute monocyte count (AMC), and absolute neutrophil count (ANC) as potential readily available prognostic biomarkers in human ICH.

      Methods

      In a retrospective study, adult patients aged 18 years or older who presented to 1 of 2 local hospitals with nontraumatic ICH from July 2008 to December 2009 within 12 hours of symptom onset were identified. Demographics, Glasgow Coma Scale (GCS), ICH volume, ICH location, and 30-day case fatality rates were determined. Total WBC count, ANC, AMC, and hemoglobin concentration were determined. Linear and logistic regressions were used to evaluate factors associated with baseline ICH volume (log transformed) and 30-day case fatality, respectively.

      Results

      Of the 186 patients, mean (±SD) age was 67.3 ± 14.8 years; 51% were men and 22% were black. Median (interquartile range) ICH volume was 12.8 (4.9, 29.4) mL. After adjusting for patient age and initial hemoglobin, higher initial WBC count (P = .0009) and higher ANC (P = .006) were associated with higher ICH volume, whereas AMC was not (P = .4). After adjusting for patient age, GCS, intraventricular hemorrhage (+/−), stroke location, and ICH volume, baseline AMC was associated with greater odds of 30-day case fatality (odds ratio 2.26, 95% confidence interval 1.10-4.65, P = .03).

      Conclusions

      The association of AMC with higher 30-day case fatality after ICH is hypothesis generating. Given the lack of association between presenting AMC and ICH volume, AMC may contribute to secondary injury after ICH (hematoma expansion and/or cerebral edema).

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Morgenstern L.B.
        • Hemphill III, J.C.
        • Anderson C.
        • et al.
        Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2010; 41 ([Practice Guideline]): 2108-2129
        • Adeoye O.
        • Broderick J.P.
        Advances in the management of intracerebral hemorrhage.
        Nat Rev Neurol. 2010; 6 ([Review]): 593-601
        • Broderick J.P.
        • Brott T.G.
        • Duldner J.E.
        • et al.
        Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality.
        Stroke. 1993; 24: 987-993
        • Brott T.
        • Broderick J.
        • Kothari R.
        • et al.
        Early hemorrhage growth in patients with intracerebral hemorrhage.
        Stroke. 1997; 28: 1-5
        • Zazulia A.R.
        • Diringer M.N.
        • Derdeyn C.P.
        • et al.
        Progression of mass effect after intracerebral hemorrhage.
        Stroke. 1999; 30: 1167-1173
        • Wang J.
        Preclinical and clinical research on inflammation after intracerebral hemorrhage.
        Prog Neurobiol. 2010; 92 ([Research Support, N.I.H., Extramural Research Support, Non-U.S. Government Review]): 463-477
        • Wang J.
        • Dore S.
        Inflammation after intracerebral hemorrhage.
        J Cereb Blood Flow Metabol. 2007; 27 ([Research Support, N.I.H., Extramural Research Support, Non-U.S. Government Review]): 894-908
        • Zhao X.
        • Zhang Y.
        • Strong R.
        • et al.
        15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats.
        J Cereb Blood Flow Metabol. 2006; 26 ([Research Support, N.I.H., Extramural]): 811-820
        • Sansing L.H.
        • Harris T.H.
        • Kasner S.E.
        • et al.
        Neutrophil depletion diminishes monocyte infiltration and improves functional outcome after experimental intracerebral hemorrhage.
        Acta Neurochirurgica Suppl. 2011; 111 ([Research support, N.I.H., Extramural Research Support, Non-U.S. Government]): 173-178
        • Sansing L.H.
        • Harris T.H.
        • Welsh F.A.
        • et al.
        Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage.
        Ann Neurol. 2011; 70 ([Research Support, N.I.H., Extramural Research Support, Non-U.S. Government]): 646-656
        • Kumar M.A.
        • Rost N.S.
        • Snider R.W.
        • et al.
        Anemia and hematoma volume in acute intracerebral hemorrhage.
        Crit Care Med. 2009; 37: 1442-1447
        • Agnihotri S.
        • Czap A.
        • Staff I.
        • et al.
        Peripheral leukocyte counts and outcomes after intracerebral hemorrhage.
        J Neuroinflamm. 2011; 8: 160
        • Sun W.
        • Peacock A.
        • Becker J.
        • et al.
        Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage.
        J Clin Neurosci. 2012; 19 ([Research Support, N.I.H., Extramural Research Support, Non-U.S. Government]): 1096-1100
        • Leira R.
        • Davalos A.
        • Silva Y.
        • et al.
        Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.
        Neurology. 2004; 63 ([Multicenter Study]): 461-467
        • Gratchev A.
        • Sobenin I.
        • Orekhov A.
        • et al.
        Monocytes as a diagnostic marker of cardiovascular diseases.
        Immunobiology. 2012; 217 ([Research Support, Non-U.S. Government Review]): 476-482
        • Angelillo-Scherrer A.
        Leukocyte-derived microparticles in vascular homeostasis.
        Circ Res. 2012; 110: 356-369
        • Maugeri N.
        • Rovere-Querini P.
        • Slavich M.
        • et al.
        Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction.
        J Immunol. 2011; 187: 970-979
        • Keating F.K.
        • Butenas S.
        • Fung M.K.
        • et al.
        Platelet-white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells.
        Transfusion. 2011; 51: 1086-1095
        • Osterud B.
        Tissue factor expression in blood cells.
        Thrombosis Res. 2010; 125: S31-S34
        • Rodriguez-Yanez M.
        • Brea D.
        • Arias S.
        • et al.
        Increased expression of Toll-like receptors 2 and 4 is associated with poor outcome in intracerebral hemorrhage.
        J Neuroimmunol. 2012; 247 ([Research Support, Non-U.S. Government]): 75-80
        • Flaherty M.L.
        • Woo D.
        • Haverbusch M.
        • et al.
        Racial variations in location and risk of intracerebral hemorrhage.
        Stroke. 2005; 36: 934-937
        • Adeoye O.
        • Haverbusch M.
        • Woo D.
        • et al.
        Is ED disposition associated with intracerebral hemorrhage mortality?.
        Am J Emerg Med. 2011; 29: 391-395
        • Conductier G.
        • Blondeau N.
        • Guyon A.
        • et al.
        The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.
        J Neuroimmunol. 2010; 224: 93-100
        • Chen Y.
        • Hallenbeck J.M.
        • Ruetzler C.
        • et al.
        Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
        J Cereb Blood Flow Metab. 2003; 23 ([Research Support, U.S. Government, Non-P.H.S.]): 748-755